A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient
Yıl: 2023 Cilt: 4 Sayı: 2 Sayfa Aralığı: 78 - 81 Metin Dili: İngilizce DOI: 10.14744/hf.2023.2023.0006 İndeks Tarihi: 03-06-2023
A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient
Öz: This study is written to report a case of 67-year-old female with known au toimmune hepatitis (AIH) who developed balance and walking difficulties. Clinical and imaging investigations were more suggestive of AIH suffering from lymphoproliferative disease. To identify the underlying suspected lym phoproliferative disease, series of brain scans were performed, which showed multiple brain lesions. This is a report on a striking case of multiple contrast enhanced brain lesions discovered in an AIH patient that was resolved upon withdrawal of azathioprine. Many side effects of azathioprine are acknowl edged around the world; however, to the very best of our knowledge, an article on azathioprine inducing suspected malignancy was never reported.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- 1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol 2015;63(4):971-1004. Erra tum in: J Hepatol 2015;63(6):1543-1544.
- 2. Munz M, Pretscher D, Wilhelm M, Holzgrabe U, Sörgel F, Birkmann J. Azathioprine-induced reversible EBV-associated Hodgkin-like lymphoma after immunosuppressive therapy for autoimmune hepatitis . Int J Clin Pharmacol Ther 2018;56(3):142-147.
- 3. Sawadogo A, Boursier J, Calès P, Oberti F, Schmidt A. Lymphome malin non hodgkinien au cours d’une hépatite chronique auto-immune traitée par azathioprine [Non hodgkin’s lymphoma associated with chronic au to-immune hepatitis treated with azathioprine]. Gastroenterol Clin Biol 2008;32(2):143-145. [French]
- 4. Wiegand J, Schüler A, Kanzler S, Lohse A, Beuers U, Kreisel W, et al. Budesonide in previously untreated autoimmune hepatitis. Liver Int 2005;25(5):927-934.
| APA | Ali hasan a, Bulut E, Keskin O (2023). A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient. , 78 - 81. 10.14744/hf.2023.2023.0006 |
| Chicago | Ali hasan aysha,Bulut Elif,Keskin Onur A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient. (2023): 78 - 81. 10.14744/hf.2023.2023.0006 |
| MLA | Ali hasan aysha,Bulut Elif,Keskin Onur A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient. , 2023, ss.78 - 81. 10.14744/hf.2023.2023.0006 |
| AMA | Ali hasan a,Bulut E,Keskin O A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient. . 2023; 78 - 81. 10.14744/hf.2023.2023.0006 |
| Vancouver | Ali hasan a,Bulut E,Keskin O A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient. . 2023; 78 - 81. 10.14744/hf.2023.2023.0006 |
| IEEE | Ali hasan a,Bulut E,Keskin O "A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient." , ss.78 - 81, 2023. 10.14744/hf.2023.2023.0006 |
| ISNAD | Ali hasan, aysha vd. "A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient". (2023), 78-81. https://doi.org/10.14744/hf.2023.2023.0006 |
| APA | Ali hasan a, Bulut E, Keskin O (2023). A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient. Hepatology forum, 4(2), 78 - 81. 10.14744/hf.2023.2023.0006 |
| Chicago | Ali hasan aysha,Bulut Elif,Keskin Onur A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient. Hepatology forum 4, no.2 (2023): 78 - 81. 10.14744/hf.2023.2023.0006 |
| MLA | Ali hasan aysha,Bulut Elif,Keskin Onur A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient. Hepatology forum, vol.4, no.2, 2023, ss.78 - 81. 10.14744/hf.2023.2023.0006 |
| AMA | Ali hasan a,Bulut E,Keskin O A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient. Hepatology forum. 2023; 4(2): 78 - 81. 10.14744/hf.2023.2023.0006 |
| Vancouver | Ali hasan a,Bulut E,Keskin O A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient. Hepatology forum. 2023; 4(2): 78 - 81. 10.14744/hf.2023.2023.0006 |
| IEEE | Ali hasan a,Bulut E,Keskin O "A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient." Hepatology forum, 4, ss.78 - 81, 2023. 10.14744/hf.2023.2023.0006 |
| ISNAD | Ali hasan, aysha vd. "A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient". Hepatology forum 4/2 (2023), 78-81. https://doi.org/10.14744/hf.2023.2023.0006 |
